GUTS
Fractyl Health, Inc. Common Stock
NASDAQ: GUTS · HEALTHCARE · BIOTECHNOLOGY
$0.64
+5.90% today
Updated 2026-04-30
Market cap
$103.61M
P/E ratio
—
P/S ratio
7,575.74x
EPS (TTM)
$-1.86
Dividend yield
—
52W range
$0 – $3
Volume
2.3M
Fractyl Health, Inc. Common Stock (GUTS) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-27.73M | $-31.07M | $-33.46M | $-46.24M | $-42.82M | $-65.52M | $-90.33M |
| Capital expenditures | $97000.00 | $2000.00 | $51000.00 | $56000.00 | $359000.00 | $1.76M | $557000.00 |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | $2.52M | $1.63M | $2.09M | $3.14M | $4.30M | $14.43M | $6.68M |
| Free cash flow | $-27.83M | $-31.07M | $-33.51M | $-46.30M | $-43.18M | $-67.29M | $-90.89M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — |